or metastatic human epidermal growth factor receptor 2 (HER2)–positive biliary tract cancer. A conditional marketing authorization is granted to a medicinal product that fulfills an unmet ...

New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...

Certain pancreatic cancer subtypes, including squamous cell carcinoma, mucinous cystadenocarcinoma, and neuroendocrine tumors, were excluded due to their rarity and varying biologic characteristics.

"This positive CHMP opinion is a welcome step for physicians and patients in Europe who face a critical unmet need in HER2-positive biliary tract cancers, a rare and aggressive group of cancers ...

This study aims to explore the use of volatile organic compounds (VOCs) in serum to distinguish BTC and benign biliary diseases (BBD). Method: We collected 158 serum samples from BTC and BBD patients, ...